A detailed history of Barclays PLC transactions in Si Bone, Inc. stock. As of the latest transaction made, Barclays PLC holds 96,623 shares of SIBN stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96,623
Previous 96,623 -0.0%
Holding current value
$1.17 Million
Previous $1.35 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$12.9 - $17.11 $817,885 - $1.08 Million
63,402 Added 190.85%
96,623 $1.35 Million
Q2 2024

Aug 14, 2024

SELL
$11.93 - $16.34 $254,490 - $348,564
-21,332 Reduced 39.1%
33,221 $430,000
Q1 2024

May 15, 2024

SELL
$15.15 - $21.58 $400,126 - $569,949
-26,411 Reduced 32.62%
54,553 $892,000
Q4 2023

Feb 15, 2024

BUY
$15.75 - $21.38 $892,678 - $1.21 Million
56,678 Added 233.38%
80,964 $1.7 Million
Q3 2023

Nov 07, 2023

BUY
$20.22 - $27.36 $190,108 - $257,238
9,402 Added 63.17%
24,286 $516,000
Q2 2023

Aug 03, 2023

SELL
$19.39 - $28.9 $71,646 - $106,785
-3,695 Reduced 19.89%
14,884 $401,000
Q1 2023

May 04, 2023

BUY
$12.71 - $21.17 $37,799 - $62,959
2,974 Added 19.06%
18,579 $365,000
Q4 2022

Feb 13, 2023

BUY
$11.23 - $19.44 $155,445 - $269,088
13,842 Added 785.14%
15,605 $212,000
Q3 2022

Nov 03, 2022

SELL
$12.2 - $18.71 $23,045 - $35,343
-1,889 Reduced 51.73%
1,763 $31,000
Q2 2022

Aug 12, 2022

SELL
$12.05 - $22.74 $44,910 - $84,751
-3,727 Reduced 50.51%
3,652 $48,000
Q1 2022

May 16, 2022

SELL
$18.32 - $23.03 $624,876 - $785,530
-34,109 Reduced 82.21%
7,379 $167,000
Q4 2021

Feb 14, 2022

BUY
$18.75 - $24.8 $461,550 - $610,476
24,616 Added 145.9%
41,488 $922,000
Q3 2021

Nov 09, 2021

BUY
$19.65 - $31.89 $145,429 - $236,017
7,401 Added 78.14%
16,872 $361,000
Q2 2021

Aug 13, 2021

SELL
$29.4 - $35.96 $431,562 - $527,856
-14,679 Reduced 60.78%
9,471 $298,000
Q1 2021

May 13, 2021

BUY
$28.09 - $34.02 $396,125 - $479,750
14,102 Added 140.35%
24,150 $768,000
Q4 2020

Feb 11, 2021

SELL
$20.44 - $30.88 $31,763 - $47,987
-1,554 Reduced 13.39%
10,048 $301,000
Q3 2020

Nov 12, 2020

SELL
$15.68 - $24.28 $129,783 - $200,965
-8,277 Reduced 41.64%
11,602 $275,000
Q2 2020

Aug 12, 2020

BUY
$10.56 - $18.46 $85,958 - $150,264
8,140 Added 69.34%
19,879 $316,000
Q1 2020

May 13, 2020

SELL
$8.36 - $22.67 $88,724 - $240,596
-10,613 Reduced 47.48%
11,739 $140,000
Q4 2019

Feb 10, 2020

BUY
$15.73 - $21.81 $48,920 - $67,829
3,110 Added 16.16%
22,352 $481,000
Q3 2019

Nov 14, 2019

SELL
$17.15 - $20.26 $18,264 - $21,576
-1,065 Reduced 5.24%
19,242 $340,000
Q2 2019

Aug 14, 2019

BUY
$15.13 - $20.34 $36,690 - $49,324
2,425 Added 13.56%
20,307 $413,000
Q1 2019

May 15, 2019

BUY
$17.29 - $22.35 $305,739 - $395,215
17,683 Added 8885.93%
17,882 $337,000
Q4 2018

Feb 14, 2019

BUY
$16.79 - $21.0 $3,341 - $4,179
199 New
199 $4,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $417M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.